January 08, 2025 05:03 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad
China upset over disclosure of its vaccine price in Bangladesh

China upset over disclosure of its vaccine price in Bangladesh

Jun 07, 2021, at 01:52 am

Bangladesh Foreign Minister AK Abdul Momen has said China is a little upset that the procurement price of Sinopharm vaccine was made public in Bangladesh, The Daily Star reported.

WHO approves Chinese COVID-19 vaccine for emergency use

WHO approves Chinese COVID-19 vaccine for emergency use

May 08, 2021, at 06:58 pm

New York: A COVID-19 vaccine produced in China has been given the green light for global rollout, potentially paving the way for its use in underserved countries, the World Health Organization (WHO) announced on Friday.  

Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers: Study   

Chinese vaccine candidate based on inactivated SARS-CoV-2 virus appears safe and induces an immune response in healthy volunteers: Study   

Nov 18, 2020, at 02:23 pm

Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.

Chinese vaccine trials in Brazil to resume after situation analysis by committee : Reports

Chinese vaccine trials in Brazil to resume after situation analysis by committee : Reports

Nov 11, 2020, at 04:16 pm

Buenos Aires/Sputnik: Trials of the Chinese vaccine Coronavac in Brazil will resume after an analysis of the situation by a special committee, according to the G1 portal, which cited National Health Surveillance Agency ANVISA chief Antonio Torres.